Trials / Recruiting
RecruitingNCT06941610
An Evaluation of the Erchonia Laser As a Non-Invasive Treatment to Improve the Appearance of Skin Laxity
An Evaluation of the Erchonia Corporation GVS Laser As a Non-Invasive Treatment to Improve the Appearance of Skin Laxity on the Abdominal Region
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 35 (estimated)
- Sponsor
- Erchonia Corporation · Industry
- Sex
- All
- Age
- 22 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this clinical study is to determine the effectiveness of the Erchonia® GVS in improving the appearance of skin laxity on the abdominal region.
Detailed description
This clinical study is a prospective open-label design with post-study independent blinded outcome analysis to evaluate the efficacy of the Erchonia® GVS Laser in improving the appearance of skin laxity on the abdominal region. Participants will receive 8 treatments over the course of 4 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Erchonia GVS Laser | 405nm violet and 520nm green laser light therapy. |
Timeline
- Start date
- 2025-05-30
- Primary completion
- 2026-08-01
- Completion
- 2026-11-01
- First posted
- 2025-04-24
- Last updated
- 2025-09-11
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06941610. Inclusion in this directory is not an endorsement.